🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

33 results for “Aclaris” Clear

  1. ATI-501 400mg BID (Low dose)

    Aclaris Therapeutics

    Alopecia

    phase 2 small molecule completed

    1 trial

  2. ATI-502

    Aclaris Therapeutics

    Atopic Dermatitis

    phase 2 small molecule completed

    1 trial

  3. Vehicle

    Aclaris Therapeutics

    Alopecia Universalis (AU)

    phase 2 small molecule completed

    1 trial

  4. Zumsemetinib

    Aclaris Therapeutics

    Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer

    phase 2 small molecule active

    1 trial

  5. A Phase 1b, Double-Blind Study to Investigate Safety, Tolerability, Pharmacokinetics, Efficacy, and Pharmacodynamics of Single Dose of ATI-052 in Participants with Mild to Moderate Asthma

    Aclaris Therapeutics

    Mild to Moderate Asthma

    phase 1 other active

    1 trial

  6. ATI-2231

    Aclaris Therapeutics

    Advanced Solid Tumor

    phase 1 small molecule terminated

    1 trial

  7. Zunsemetinib

    Aclaris Therapeutics

    Metastatic Pancreatic Ductal Adenocarcinoma

    phase 1 small molecule active

    1 trial

  8. A-101 Topical Solution

    Aclaris Therapeutics

    Seborrheic Keratosis

    approved small molecule completed

    1 trial

  9. Oxymetazoline HCL 1.0% Cream

    Aclaris Therapeutics

    Rosacea

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources